2018 American Transplant Congress Archives - Page 39 of 211

p16^INK4a Deletion in Vascular Endothelium Improves Kidney Regeneration Post Ischemia Reperfusion Injury

A. Melk,¹ A. Baisantry,^1,2 S. Wang,¹ F. Kubaink,¹ R. Bhayadia,¹ R. Schmitt.²
p40 Homodimer Induced Proliferation of Endogenous Donor-Reactive Memory CD8 T Cells within High Risk Allografts Requires Memory CD8 T Cell Expression of CD122

H. Tsuda, A. Valujskikh, R. Fairchild.
Pancreas and Kidney Co-Transplantation in Type II Diabetes: A Single Center Experience

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.
Pancreas Decellularization Protocol – Comparison of Methods

A. Berman, K. Karzynski, M. Serwanska-Swientek, N. Pilka, M. Klak, K. Kosowska, J. Cichon, F. Ambrozkiewicz, M. Wszola.
Pancreas Graft Function >10 Years: The Cumulative US Experience

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
Pancreas Outcomes between Living and Deceased Kidney Donor Recipients in Pancreas after Kidney Transplantation

P. Ventura-Aguiar,¹ J. Ferrer,² I. Revuelta,¹ D. Paredes,³ E. De-Sousa,¹ J. Rovira,⁴ E. Esmatjes,⁵ J. Garcia-Valdecasas,² F. Oppenheimer,¹ F. Diekmann,¹ M. Ricart.¹
Pancreas Retransplantation: Outcomes of This Technical and Immunological Challenge over 38 Patients

F. Paret,¹ D. Cantarovich,² G. Karam,³ T. Batard,⁴ M. Nedelec,⁵ J. Branchereau.⁶
Pancreas Transplant Alone (PTA) Outcome is Best in Brittle Diabetic Patients without Advanced Nephropathy

M. Laftavi,¹ A. Gruessner,² O. Pankewycz,¹ B. Kaylene,² S. Sidharth,² R. Gruessner.
Pancreas Transplant for Type 2 Diabetes is Associated with Preserved Function, but Impaired Glucose Tolerance: A Comparative Analysis

S. Doshi, C. Pulitano, D. Al-Adra, A. Norgate, G. Sapisochin, M. Selzner, I. McGilvray, J. Schiff, M. Cattral.
Pancreas Transplant in the Elderly Patient – Should It Be Done?

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation

Y. Tang, Z. Zhu, S. Huang, Z. Zhang, W. Ju, Z. Guo, X. He, G. Chen.
Pancreatic Graft Loss after Simultaneous Pancreas Kidney (SPK) Transplant within First 90 Days. Predictors beyond the Surgical Cause. A UNOS/OPTN Data Analysis

H. Sharma, M. Abraham, J. Chen, D. Mikhail, S. Aquil, S. Patel, A. Skaro, V. McAlister, A. Sener, P. Luke.
Parathyroid Cell Xenotransplantation with Ultrapure Alginate Based Microencapsulation Technique

B. Goncu,¹ E. Yucesan,² H. Basoglu,³ M. Celikten,¹ O. Huseyinbas,¹ B. Ozdemir,¹ N. Ozten Kandas,⁴ F. Akbas,⁵ Y. Ersoy,⁶ E. Aysan.⁶
Parathyroidectomy Outcomes in Renal Transplant Recipients: Subtotal vs. Total

R. Rathore,^1,2 A. Sharma,² A. Halawa.²
Parsing the 100% CPRA Kidney Transplant Candidates, Who Gets Transplanted?

D. Keith.
Participation in Paid Work across the Transplant Trajectory from the Perspective of End-Stage-Kidney-Disease Patients

K. Gaudet, M. Achille.
Patient and Graft Survival in Pediatric Renal Transplant Recipients Compared to Adult Multi-Organ (Kidney-Pancreas, Simultaneous Liver-Kidney, or Heart-Kidney) Transplant Recipients: An Analysis of OPTN Data

P. Almond,¹ S. Al-Akash,¹ D. Stewart,² A. Robinson.²
Patient and Transplant Outcome in Infants Starting Renal Replacement Therapy before Two Years of Age

J. Hogan,^1,2,3 J. Harambat,⁴ E. Berard,⁵ C. Couchoud,³ M-.A. Macher.^2,3
Patient Attitudes and Perceptions of Using Mobile Health Technology for Living Kidney Donor Follow-Up and Care Management

A. Eno,¹ A. Thomas,¹ J. Ruck,¹ S. Rasmussen,¹ S. Halpern,¹ D. Segev,^1,2,3 M. Henderson.^1,3
Patient Change in Residence and Risk of Readmission after Renal Transplant in the US

J. Hogan, M. Anderson, Y. Zhang, J. Kim, G. Karadkhele, X. Zhang, A. Adams, R. Patzer.
Patient Experience after Kidney Transplant: Factors That Lessen the Burden of Treatment after Kidney Transplant

E. Lorenz,¹ J. Egginton,¹ M. Stegall,¹ R. Heilman,² S. Nair,² M. Mai,³ D. Eton.¹
Patient-Centered Outcomes after Liver Transplantation: A Qualitative Study

G. Lee, J. Obayemi, E. Rubin.
Patient-Researcher Partnership Platform within the Canadian National Transplant Research Program: The First Year Experience

M-.C. Fortin,^2,3,6 S. Bédard,^1,2 J. Allard,^2,3 F. Ballesteros,^2,3 S. Anthony,^2,4,5 A. Boivin,^1,3 A. Lespérance,^1,3 D. Hartell.²
Patients Converted to Belatacept Show Different Immunophenotyping Compared with De Novo Belatacept-Treated Patients

M. Rial,¹ F. Caro,² A. Nella,² D. Guerrieri,² L. León,¹ P. Uva,¹ E. Chuluyan,² D. Casadei.¹
Patients Prioritize Waitlist Factors over Outcomes When Evaluating Kidney Transplant Centers

A. Michelson, C. Brennan, A. Mattoo, B. Kil, D. Tsapepas, S. Husain, S. Mohan.
Patients with C-aABMR and V-Lesions in Their Renal Transplant Biopsy Have a Superior Response to Treatment

K. Sablik, M. Clahsen-van Groningen, C. Looman, M. Betjes.
Pattern of Respiratory Virus Infection (RVI) and Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant Recipients (LTR)

L. Somerville, S. Drews, K. Halloran, N. Lee, D. Kabbani, H. Hirji, K. Doucette, C. Cervera.
PD-L1 May Serve as a Biomarker for Chimerism-Induced Tolerance in Kidney Transplant Recipients

A. Merchak,¹ A. Khalil,¹ A. Chhabra,¹ J. Leventhal,² S. Ildstad.¹
Pediatric Kidney Allograft Outcomes Following Identification of Transplant Glomerulopathy by Electron Microscopy

J. Grodsky, R. Craver, I. Ashoor.
Pediatric Kidney Transplant in Norway – Results after Switching from Midline to Retroperitoneal Approach in Recipients below 25 kg

R. Horneland, A. Khan, G. Steinar, T. Thorsen, M. Hagness.
Pediatric Transplantation within the ASTS: A Member Survey

W. Andrews, S. Chinnakotla, J. Nathan, A. Gallo, P. Healey, J. Dominique, C. Esquivel.
Peptides Encoded by EBV Latent Cycle Proteins Affect NK Cell Reactivity

B. Mbiribindi, C. Romero Moreno, C. Esquivel, O. Martinez, S. Krams.
Perceptions, Motivations, and Concerns about Living Organ Donation among People Living with HIV

S. Rasmussen, M. Henderson, J. Bollinger, S. Seaman, C. Durand, D. Segev, J. Sugarman.
Performance of Molecular Diagnostic Algorithms of T-Cell Mediated Kidney Rejection (TCMR) in Non-Transplant Biopsies with Interstitial Nephritis

Z. Wang,¹ P. Liu,² G. Tseng,² G. Zeng,¹ P. Randhawa.¹
Peri-Operative Hemoglobin, Blood Transfusion and Delayed Graft Function in Kidney Transplant Recipients

S. MacIsaac, A. Ramankumar, C. Saw, V. Naessens, M. Cantarovich, D. Baran, S. Paraskevas, J. Tchervenkov, P. Chaudhury, S. Sandal.
Peri-Transplant Glycaemic Control as a Predictor of Pancreas Transplant Survival

M. Shapey,^1,2 R. Tan,¹ H. Khambalia,² C. Fullwood,² P. Yianoullou,^1,2 A. Summers,² T. Augustine,² M. Rutter,¹ D. van Dellen.²
Peripheral Blood Immune Response-Related Gene Analysis for Evaluating the Development of Subclinical Antibody-Mediated Rejection

T. Yamamoto,¹ K. Iwasaki,² K. Murotani,³ A. Takeda,⁴ M. Tsujita,⁴ T. Hiramitsu,⁴ N. Goto,⁴ S. Narumi,⁴ Y. Watarai,⁴ K. Uchida,² T. Kobayashi.⁵
Peripheral but Not Follicular T Helper Cells Are Activated by Allogeneic Human Endothelial Cells under IRI-Like Conditions and Promote Donor Specific Antibody

W. Fu,¹ P. Yoo,² J. Pober,³ D. Jane-wit.¹
Persistence and Homing of Autologous Donor-Reactive Ex-Vivo Expanded Regulatory T Cells to Heart Allografts in Lymphodepleted Recipient Monkeys

M. Ezzelarab, Z. Hong, A. Zahorchak, L. Lien, T. Nakao, H. Dai, D. van der Windt, A. Perez-Gutierrez, J. Bhama, A. Thomson.
Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation

T. Hussaini,^1,4 N. Partovi,^1,4 E. Yoshida,^2,4 S. Erb,^2,4 C. Scudammore,^3,4 S. Chung,^3,4 V. Marquez.^2,4
PGE2/Beta-Catenin/XBP1 Signaling Controls Mesenchymal Stem Cell-Mediated Immune Regulation in Liver Ischemia and Reperfusion Injury

C. Li, S. Yue, L. Jiang, Q. Zhu, D. Farmer, R. Busuttil, J. Kupiec-Weglinski, B. Ke.
Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients

Z. Wang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu.
Pharmacokinetics of Mycophenolic Acid Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients

W. Peng, C. Tian, Z. Chen, W. Xue, G. Wang, Q. Ye, X. Zhang, M. Gu, M. Zhao, C. Wang, C. Huang, J. Yan, W. Zhang, C. Ding, Y. Fu, S. Ye, X. Hu, R. Tan, M. Li, R. Deng, Y. Ke, W. Wu, M. Fan, J. Chen.
Pharmacologic Donor Management Influences Liver Transplant Graft Survival and Transplant Admission Length of Stay: An Update

J. Brandenberger,¹ J. Perkins,² A. Cantafio,³ A. Dick,² J. Halldorson,⁴ J. Reyes.²
Pharmacological Defatting of Steatotic Human Livers Using a Novel Perfusion Solution during Normothermic Machine Perfusion

Y. Boteon,^1,2 J. Attard,^1,2 R. Laing,^1,2 A. Boteon,¹ R. Bhogal,¹ G. Reynold,² D. Neil,¹ H. Mergental,¹ D. Mirza,¹ S. Afford.²
Phosphoproteomic Analysis of Mouse Hepatic Ischemia/Reperfusion Injury

A. Zarrinpar,² S. Duarte,¹ Y. Lai.²
Pilot Study of Health IT Feasibility and Impact on Quality of Life for Young Adult Kidney Transplant Recipients

C. Blosser, R. Katz, J. Himmelfarb, N. Bansal.
Pilot Study of Plasma Cell Niche-Targeted Therapy for Enhancement of Proteasome Inhibitor Effectiveness

S. Tremblay,¹ C. Castro-Rojas,² J. Driscoll,¹ S. Knechtle,³ A. Shields,¹ R. Alloway,¹ H. Singh,² D. Hildeman,² E. Woodle.¹
Pinching an Inch in Kidney Transplantation: Subcutaneous Depth as a Risk Factor for Wound Complications

R. Ruiz, T. Cox, K. Wicklund, N. Jennings, N. Onaca, G. Testa, T. Anthony, H. Fernandez, J. Bayer, G. McKenna.
Platelet Counts as Predictors of Short- and Long-Term Outcomes in Liver Transplantation: Cassandras or Just Rats on a Sinking Ship?

I. Amygdalos,¹ Z. Czigany,¹ J. Böcker,¹ F. Meister,¹ M. Krebbers,¹ D. Morales Santana,¹ J. Bednarsch,¹ W. Schöning,¹ F. Ulmer,¹ G. Koek,³ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes

S. Marx,¹ C. Adam,² S. Leyking,² U. Sester,² M. Sester.
Polymorphisms of Nucleotide Factor of Activated T Cells Cytoplasmic 2 and 4 and the Risk of Acute Rejection Following Kidney Transplantation

Z. Wang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu.
Population-Based Modeling of Prototypes and Determinants of Allograft Function Trajectories after Kidney Transplantation: Implications for Patient Monitoring and Risk Stratification

M. Raynaud, O. Aubert, M. Naessens, E. Morelon, M. Giral, N. Kamar, E. Wong, S. Jordan, B. Orandi, D. Segev, M. Stegal, P. Reese, C. Lefaucheur, A. Loupy.
Portal Vein Flow as an Indicator of Liver Transplantation for Acute Liver Failure

C-.H. Cheng,¹ C. Lee,² Y-.C. Wang,¹ T-.H. Wu,¹ C-.F. Lee,¹ T-.J. Wu,¹ H. Chou,¹ K-.M. Chan,¹ W-.C. Lee.¹
Portal Vein Thrombosis (PVT) in Liver Transplantation – Recent Experience

D. Bruce, H. Bohorquez, J. Seal, A. Cohen, E. Bugeaud, I. Carmody, D. Sonnier, A. Mathur, L. De Gregorio, H. Sharma, G. Loss.
Positive Implications of an Enhanced Recovery after Surgery Protocol Using Liposomal Bupivacaine for Transverse Abdominis Plane Block in the Perioperative Phase of Robotic Assisted Laparoscopic Living Donor Nephrectomy

A. Nickkholgh,¹ A. Agarwal,¹ B. Sarosiek,² A. Sites,³ A. Nishio Lucar,⁴ J. Oberholzer,¹ P. Amato.⁵
Positive Relationship between Transplant Center Volume and Utilization of Hard to Place Liver Allografts after Late Declines

J. Knox,¹ H. Braun,¹ S. Syeed,¹ K. Halazun,² G. Roll.¹
Post Reperfusion Portal Flow Rate Impacts Liver Allograft and Patient Survival in Patients with Pre Transplant Portal Vein Thrombosis

M. Rizzari, M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud.
Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study

F. Shihab,¹ Y. Qazi,¹ V. Peddi,¹ D. Shaffer,¹ K. McCague,² D. Patel,² S. Mulgaonkar.¹
Post-Transplant High Dose Cyclophosphamide Treatment Induces Thymus-Independent Immune Tolerance of Vascularized Composite Allografts via Complete Depletion of the Alloreactive TCR Repertoire.

G. Furtmüller,¹ B. Oh,¹ J. Sidhom,² M. Fryer,¹ V. Malek,¹ X. Zhou,¹ D. Cooney,¹ C. Brayton,³ J. Dodd-o,⁴ S. Ganguly,² G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹
Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation: A Single Institute Experience with Focus on Epstein-Barr Virus Status

P. Zhang,¹ R. King,¹ K. Ristow,² L. Cornell,¹ F. Cosio,³ T. Habermann,² M. Alexander.¹
Post-Transplant Outcomes under the New HCC Exception Policy

T. Ishaque, A. Massie, C. Haugen, D. Segev.
Post‐Donation eGFR Levels Predicts New‐Onset Antihypertensive Medication Use after Living Kidney Donation

K. Lentine,¹ D. Segev,² N. Lam,³ A. Garg,⁴ A. Naik,⁵ D. Axelrod,⁶ H. Xiao,¹ M. Henderson,² A. Massie,² B. Kasiske,⁷ G. Hess,⁸ C. Hsu,⁹ D. Brennan,² M. Schnitzler.¹
Postoperative Immunological Profiles of Adult ABO-Incompatible Living Donor Liver Transplant Recipients

T-.J. Wu, Y-.C. Wang, C-.H. Cheng, T-.H. Wu, C-.F. Lee, H. Chou, K-.M. Chan, W-.C. Lee.
Postoperative Renal Function Predicts Length of Stay for Incisional Hernia Repair after Liver Transplantation

J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Potential Barriers to Renal Patient Care: Perspectives of Dialysis and Transplant Social Workers

D. Lim,¹ A. Patel,² N. Khoury,² R. Prashar.²
Potential Impact of DCD Donor Recoveries on Heart Transplantation: Retrospective Analysis of a Limited UNOS Dataset

J. Lindower,² M. Farr,¹ S. Taylor,² U. Jorde,³ L. Chen,⁴ A. Gass,⁵ L. Truby,¹ S. Delair,² S. Pinney.⁶
Potential Living Donors Identified through Social Media

S. Weeks, K. Kumar, J. Konel, E. King, M. Henderson, A. Cameron, J. Garonzik Wang.
Poverty, End Stage Liver Disease, and Transplantation in Georgia

R. Lynch,¹ K. Ross,¹ J. Magliocca,¹ D. Goldberg,² R. Patzer.¹
Pragmatic Surgical Risk Assessment Criteria in Critically Ill Patients Prior to Liver Transplantation

C. Bonham, Z. Tulu, M. Melcher, P. Kwo, W. Concepcion, A. Ahmed, C. Esquivel.
Pre Liver Transplant (LT) Prediction of Surgical Complexity by Recipient Risk Grading and Optimizing Outcomes: The Ochsner Experience

H. Sharma,¹ H. Bohorquez,^1,2 D. Bruce,¹ J. Seal,¹ A. Cohen,^1,2 E. Bugeaud,¹ I. Carmody,^1,2 D. Sonnier,¹ A. Mathur,¹ D. Marroquin,¹ M. Voltz,¹ L. DeGregorio,¹ G. Loss.^1,2
Pre-Donation Body Mass Index Associations with Outcomes in Living Kidney Donors: A Single Centre Experience

A. Kousios, K. Koutroutsos, R. Charif, J. Galliford, N. Stubbs, H. Dulku, H. Orr, M. Loucaidou.
Pre-Donation eGFR, Early Post-Donation eGFR, and Subsequent ESRD Risk in Living Kidney Donors

A. Massie,¹ L. Fahmy,¹ M. Henderson,¹ A. Thomas,¹ J. Snyder,² D. Segev.¹
Pre-Emptive Rituximab and Intravenous Immunoglobulin (IVIg) Fail to Prevent Rejection in Kidney Transplant Recipients (KTx) with Donor Specific Antibodies (DSA)

J. Crew, R. Vasilescu, E. Campenot, S. Mohan, S. Patel.
Pre-Existing Allograft Diabetic Nephropathy from Diabetic Donor is Reversible after Kidney Transplantation in Non-Diabetic Recipient

K. Hotta,¹ D. Iwami,¹ H. Harada,² Y. Fukasawa,² H. Okada,¹ H. Higuchi,¹ T. Hirose,² N. Fukuzawa,² N. Shinohara.¹
Pre-Existing Renal Cell Carcinomas in Patients with Polycystic Kidney Disease Undergoing Simultaneous Native Nephrectomy and Living Donor Kidney Transplantation

M. Aull,¹ J. Del Pizzo,² A. Watkins,¹ S. Kapur.¹
Pre-Kidney Transplant Inflammation and Post-Transplant Outcomes.

H. Ying, M. McAdams DeMarco, D. Segev.
Pre-Operative Predictors of Health-Related Quality of Life for Pancreas Transplant Recipients

I. Mosca,³ S. Mittal,¹ J. Smith,² P. Friend.^1,3
Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants

S. Pineda,¹ T. Sigdel,¹ J. Chen,¹ A. Jackson,² M. Sirota,¹ M. Sarwal.¹
Pre-Transplant Duration of Dialysis, N-Terminal Pro-Brain Natriuretic Peptide and Post-Transplant Mortality in Renal Transplant Recipients

M. Yeung, M. Van Londen, U. Nakshbandi, Y. Said, M. Eisenga, B. Hepkema, M. Nolte, S. Berger, M. De Borst, S. Bakker.
Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Pre-Transplant versus De Novo Donor Specific Antibodies: Differences in Clinical Outcomes and Antibody Mediated Rejection

M. Ajaimy, N. Hayde, A. Colovai, E. Akalin.
Precision (re)Phenotyping of Histologically Stable Kidney Transplants

D. Rychkov,¹ T. Sigdel,² M. Sirota,¹ M. Sarwal.²
Precision Medicine for Determining the Efficacy of a Novel Belatacept Regimen

J. Shoji, J. Leung, E. Tavares, Q. Tang, F. Vincenti.
Predicting Acute Kidney Injury after Orthotopic Liver Transplantation Using a Recurrent Neural Network

A. Bishara, R. Kothari, M. Bokoch, C. Niemann, D. Adelmann.
Predicting Early and Late eGFR Variability in Kidney Transplant Recipients

K. Soliman, D. Taber, S. Zemin, V. Rao.
Predicting Liver Allograft Discard: The Discard Risk Index

A. Rana, M. Kueht, N. Galvan, R. Cotton, T. Miloh, C. O'Mahony, J. Goss.
Predicting Outcomes of Rat Vascularized Composite Allotransplants through Quantitative Measurement of Chimerism with PCR-Amplified Short Tandem Repeat

H. Cheng,¹ X. Huang,² C-.F. Lin,¹ N. AL Deek,² L. Shih,² C-.H. Lin,^1,2 F-.C. Wei.^1,2,3
Predicting Pediatric Liver Transplant Rejection with Peripheral Blood Leukocyte (PBL) Transcripts-Considerations and Design Limitations

M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.
Predicting Survival after Deceased-Donor Kidney Transplants by Donor-Recipient Match: Who Can Tolerate a High-KDPI Kidney?

S. Bae, J. Garonzik Wang, K. Jackson, A. Thomas, X. Luo, A. Massie, D. Segev.
Prediction of 90 Days Readmission after Kidney Transplantation Including Natural Language Processing

X. Zhang,¹ M. Arenson,⁴ J. Kim,⁴ G. Karadkhele,¹ J. Hogan,^1,5 Y. Zhang,⁶ A. Adams,¹ R. Patzer.^1,2,3
Prediction of BK Viremia by Urine BK Viral Load in Renal Transplant Patients: BK Viral Load Results in Paired Urine and Plasma Samples

K. Madden,¹ C. Janitell,² S. Yang.²
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis

A. Humar,¹ P. Liu,² J. Luo,³ M. Nalesnik,³ A. Singhi,³ G. Tseng,² G. Michalopoulos.³
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast EnhancedUltrasonography

C. Yang,¹ S. Wu,³ T. Zhu,¹ W. He.²
Predictive Scores for Delayed Graft Function Based on Hypothermic Machine Perfusion Variables in Kidney Transplantation

C. Ding,^1,2 W. Xue,^1,2 P. Tian,^1,2 X. Ding,^1,2 X. Pan,^1,2 H. Xiang,^1,2 Y. Li,^1,2 X. Tian,^1,2 F. Han,^1,2 Q. Tai.^1,2
Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation

M. Xu,¹ T. Fraum,² S. Garcia-Aroz,¹ N. Vachharajani,¹ N. Saad,³ K. Fowler,² Y. Lin,¹ W. Chapman.¹
Predictors of Early Graft Loss in Older Kidney Transplant Recipients

P. Amaechi, R. Rodriguez, V. Rao, D. Taber, M. Posadas Salas.
Predictors of Graft Survival amongst Recipients of Liver Allografts with Prolonged Cold Ischemic Time (CIT)

J. Steggerda,¹ K. Kim,¹ D. Malinoski,² M. Bloom.¹
Predictors of Graft Survival at the Time of a Kidney Transplant Indication Biopsy

G. Einecke,¹ J. Reeve,^2,3 P. Halloran.^2,4
Predictors of Immunosuppressive Medication Adherence in Chinese Renal Transplant Recipients: Marital Status and Immunosuppressive Medication Beliefs

J. Liu,¹ S. Liu,² J. Xie,¹ J. Yan.¹
Predictors of Kidney Transplant Recipient Readmissions

A. Crane, M. Eltemamy, D. Jacobsen, T. Coy, A. Sun, P. Babbar, M. Ponziano, E. Poggio, A. Wee, R. Fatica, V. Krishnamurthi.
Preemptive B Cell Depletion Modulates Pathogenic Alloimmunity Associated with Selective Non-Activating CD28 Blockade

N. O'Neill,¹ T. Zhang,¹ W. Sun,¹ G. Braileanu,¹ X. Cheng,¹ I. Tatarov,¹ W. Hassanein,¹ Z. Habibabady,¹ B. Cerel,¹ K. Reimann,² A. Azimzadeh,¹ R. Pierson.¹
Preemptive Chest Tube in Liver Transplantation – An Unconventional Way to Reduce Morbidity

P. Ritschl, L. Wiering, F. Sponholz, A. Brandl, F. Aigner, M. Biebl, M. Schmelzle, D. Eurich, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
Preemptive Plasma Therapy and Eculizumab (ECU) Rescue for Atypical Hemolytic Uremic Syndrome (aHUS) Relapse Following Kidney Transplantation (KTX)

C. Aigner,^1,2 G. Böhmig,¹ F. Eskandary,¹ M. Gaggl,¹ R. Kain,² R. Sunder-Plassmann,³ Z. Prohaszka,⁴ A. Schmidt,¹ G. Sunder-Plassmann.¹
Preemptive Rituximab in Focal and Segmental Glomerulosclerosis Patients at Risk for Recurrence after Transplantation

P. Auñon,¹ N. Polanco,¹ M. Perez,² E. Rodrigo,³ A. Sancho,⁴ J. Pascual,² A. Andres,¹ M. Praga.¹
Preformed Donor-Reactive T-Cells That Persist after ABO Desensitization Independently Predict Severe Acute Cellular Rejection after Living Donor Kidney Transplantation

T. Schachtner,^1,2,3 M. Stein,² P. Reinke.^1,2
Pregnancies in Female Pancreas Transplant Alone Recipients

P. Patel,¹ D. Kliniewski,² L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^1,2,4
Pregnancy Outcomes after Living Liver Donation

G. Lee, E. Sonnenberg, K. Olthoff, D. Goldberg, P. Abt.
Pregnancy Outcomes in Kidney Recipients with Lupus Nephritis

S. Rao,^1,2 L. Coscia,¹ D. Armenti,¹ M. Moritz,^1,3,4 S. Constantinescu.^1,2
Preoperative Anemia in Transfusion Free Patients Undergoing Kidney Transplant May Be Associated with Poor Outcome

N. Kaur, A. Pita, C. Lane, M. Bhatnagar, L. Matsuoka, R. Selby, K. Dhanireddy.
Preoperative Antibiotics Treatment Decreases Endoplasmic Reticulum Stress and Protects Liver Transplant from Ischemia-Reperfusion Injury

T. Ito, F. Kaldas, K. Nakamura, S. Kageyama, A. Aziz, R. Busuttil, J. Kupiec-Weglinski.
Preoperative Patient Education to Improve the Inpatient Experience for Living Donors

K. Ventura, K. Sigafus.
Preparation for Transfer to Adult Kidney Transplant Care: Impacts of Providing Written Guidance

H. Stephens,¹ M. Clementi,¹ A. Al-Uzri, M. Wright,⁴ S. Iragorri,² D. Rozansky,² R. Jenkins,² J. Wade,³ K. Richardson,⁵ K. Freeman.¹
Presence of Chronic Vascular Lesions on Allograft Biopsy is Associated with Greater Improvement in Renal Function after Conversion from Tacrolimus to Belatacept

M. Perez-Saez,^1,2 B. Yu,¹ A. Uffing,¹ N. Murakami,¹ J. Azzi,¹ S. El Haji,³ S. Gabardi,³ L. Riella.¹
Presence of Donor Specific Antibodies is Associated with Accelerated Podocyte Detachment

A. Naik, J. Aqeel, D. Cibrik, M. Samaniego, S. Wang, M. Chowdhury, F. Afshinnia, R. Wiggins.
Presentation and Outcomes of Post-Transplant Proliferative Disorder at a Single Institution Pediatric Transplant Center

G. Ramos-Gonzalez,¹ A. Allain,¹ T. Agur,¹ L. O'Melia,¹ S. Staffa,² S. Burchett,¹ B. Siegele,³ O. Weinberg,³ N. Rodig,¹ R. Fawaz,¹ T. Singh,¹ D. Freiberger,¹ K. Heung Bae.¹
Pretransplant Use of Rituximab is Associated with Posttransplant Malignancies Events and Death by Neoplasia in Incompatibility Living Donor Kidney Transplants

I. Revuelta,^1,2,3,4 V. Tubita,² D. Cucchiari,^1,2 E. De Sousa,¹ P. Piselli,⁵ M. Lozano,⁶ J. Cid,⁶ E. Palou,⁷ J. Martorell,⁷ F. Oppenheimer,^1,2,3,4 F. Diekmann,^1,2,3,4 J. Campistol.^1,2,3,4
Prevalence and Impact of CYP3A5 Genomic Variances on Clinical Outcomes among African-American Kidney Transplant Recipients

A. Maldonado,¹ S. Hudson,² L. Rebellato,² T. Asempa.¹
Prevalence and Infection-Related Outcomes Associated with Transplant Tourism

J. Slomovic, S. Humar, D. Kumar, A. Humar.
Prevalence and Persistence of Cardiovascular Risk Factors and Subclinical Vascular Damage in Patients after Pediatric Lung Transplantation

M. Onnen,¹ N. Memaran,¹ B. Borchert,¹ R. Blöte,¹ R. Sugianto,¹ C. Müller,² A. Melk.¹
Prevalence of Abnormal Hemoglobin A1C in Pediatric Kidney Transplant Recipients

A. Serluco,¹ R. Liverman,¹ R. George,^1,2 R. Garro.^1,2
Prevalence of Frailty among Kidney Transplant Recipients in the United States

A. Thomas,¹ A. Shaffer,¹ H. Ying,¹ S. Norman,² D. Segev,¹ M. McAdams-DeMarco.¹
Prevalence of Metabolic Syndrome (MetS) and Insulin Resistance in Living Kidney Donors

I. Agboli, L. Moore, D. Nguyen, E. Graviss, H. Ibrahim, A. Gaber, A. Sadhu.
Prevalence, Risk Factors and Impact of BK Viremia on Kidney Transplantation: Single Center Experience

W. Hassan, A. El-Husseini, B. Suleiman, K. Wang, M. Yaseen, A. Maibam, A. Karim, A. Hines, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid.
Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism

B. Oh,¹ C. Cheng,² G. Furtmüller,¹ K. Donovan,¹ W. Lee,¹ J. Powell,² G. Brandacher.¹
Preventing Recurrence of Incisional Hernia after Liver Transplantation

J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Prevention and Reversal of Diabetes through Restoration of B and T Cell Regulation and Immune Homeostasis

K. Brayman,¹ P. Chhabra,¹ C. Wilson,² A. Marshall,² D. Moore.²
Prevention of an Adaptive Immune Response by FDA-Approved Immunosuppressive Agents in Baboons with Pig Artery Patch Xenografts

T. Yamamoto,¹ H. Hara,¹ L. Wang,¹ Q. Li,¹ J. Li,¹ H. Zhou,¹ D. Eckhoff,¹ A. Tector,¹ D. Ayares,² D. Cooper,¹ H. Iwase.¹
Prevention of Hepatitis B Virus Reactivation in HBsAg-Positive Renal Transplant Recipients with Rituximab Treatment

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.
Prevention of New Onset Diabetes after Transplantation Using Bariatric Surgery

A. Bailey, Y. Kim, S. Woodle, S. Shah, F. Paterno, M. Cuffy, T. Diwan.
Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients is Associated with Prolonged Cold Ischemic Time of Seropositive Donor Organs

C. Falk,^1,7 F. Schlott,^2,7 K. Katsrintaki,^1,7 D. Steubl,³ W. Puppe,⁴ C. Blume,⁵ H. Haller,⁶ L. Renders,³ U. Heemann,³ D. Busch,² M. Neuenhahn.^2,7
Primary Insult to the Native Lungs Are Needed for Antibodies to Lung Self-Antigens, Kα1Tubulin and Collagen V, to Be Pathogenic for the Development of Obliterate Airway Disease

M. Sharma, W. Liu, T. Mohanakumar.
Primary Oral Vancomycin Prophylaxis Reduces the Incidence of Clostridium difficile Infection among Lung Transplant Recipients

V. Bajrovic, K. Brizendine.
Private Insurance is Associated with Reduce Access to HCV Therapy after Liver Transplantation

D. Axelrod,¹ M. Schnitzler,² B. Kasiske,³ G. Hess,⁴ R. Bloom,⁵ F. Gordon,¹ H. Randall,² K. Lentine.²
Pro-Inflammatory B Cells Predict Progressive Minimal Early Renal Allograft Inflammation Which is Associated with Poor Graft Outcomes

A. Sharma, A. Cherukuri, D. Chittka, R. Mehta, S. Hariharan, D. Rothstein.
Probability of Developing Chronic Kidney Disease 1 Year after Living Donor Nephrectomy Correlates with Baseline Kidney Volume and Function

I. Hall, A. Shaaban, S. Beddhu, F. Shihab.
Procurement Travel Safety: Current Practices, Accident Frequency, Perceptions of Safety and Means to Reduce Risk

A. Schenk, A. Adams, R. Lynch.
Prognostic Value and Biological Significances of Five Long Non-Coding RNAs in Hepatocellular Carcinoma

Y. Hou,¹ Z. Yu,² N. Tam,¹ S. Huang,¹ J. Yang,¹ L. Wu,¹ Y. Ma,¹ X. He.¹
Program-Specific Survival from Listing: Variability and Association with Pretransplant and Posttransplant Metrics

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Program-Specific Transplant Rate Ratios: Association with Allocation Priority at Listing and Posttransplant Outcomes

A. Wey, S. Gustafson, N. Salkowski, J. Pyke, B. Kasiske, A. Israni, J. Snyder.
Programmed Cell Death Ligand 1 (PD-L1) Expression is Associated with Subtypes of Post-Transplant Lymphoproliferative Disorders (PTLD)

N. Rodig,¹ G. Pinkus,² G. Ramos Gonzalez,³ T. Agur,¹ O. Weinberg.⁴
Progression of Vertebral Bone Disease among Kidney Allograft Recipients on Steroid Maintenance

E. Abuhelaiqa,¹ M. Alkadi,¹ M. Jarman,² J. Mahmoud,² A. Hamdi,¹ A. Ashor,¹ A. Nauman,¹ M. Asim,¹ O. Fituri,¹ H. Al-Malki.¹
Prolongation of Skin Allograft Survival through Dietary Supplementation of Ayrl Hydrocarbon Receptor Ligands

A. Afrazi, L. Owens, J. Fechner, C. O'Driscoll, J. Mezrich.
Prolonged Cold Ischemia Storage of Renal Allografts Shifts DSA Specificity and Enchances Glomerular Injury

V. Gorbacheva, R. Fan, W. Baldwin, A. Valujskikh.
Prolonged Graft Survival in Old Recipients is Abrogated by Immunosuppressive Treatment with CTLA4-Ig

T. Heinbokel,¹ M. Quante,^1,2 K. Edtinger,¹ K. Minami,¹ Y. Nian,¹ A. Lau,¹ A. Elkhal,¹ S. Tullius.¹
Prolonged-Release Tacrolimus Dosing in De Novo Kidney Transplantation: Randomized, Open-Label, Pilot Study

Y. Kim,¹ Y. Chiang,² S. Kim,³ M. Kim,⁴ S. Park,⁵ S. Wu,⁶ K. Horita,⁷ Y. Nakashima,⁷ H. Jiang,⁸ D. Han.¹
Promoting Medication Adherence from the Perspectives of Teen and Young Adult Kidney Recipients, Parents and Health Care Professionals

C. Nguyen,¹ M. Dew,¹ A. DeVito Dabbs,¹ T. Irizarry,¹ M. McNulty,¹ B. Foster.²
Prophylaxis of Wound Infections- Antibiotics in Renal Donation (POWAR): A Multicentre UK Double Blinded Placebo Controlled Randomised Controlled Trial

Z. Ahmed, R. Uwechue, N. Kessaris, N. Mamode.
Prospective Analysis of EBV+ PTLD Incidence in Pediatric Transplant Recipients in the Modern Era

O. Martinez,¹ S. Krams,¹ M. Lapasaran,¹ S. Boyd,² D. Bernstein,² C. Twist,³ K. Weinberg,² D. Gratzinger,² B. Tan,² B. Armstrong,⁴ D. Ikle,⁴ M. Brown,⁵ M. Robien,⁵ C. Esquivel,¹ The CTOTC-06 Investigators.
Prospective Multicenter Validation of Human Transitional B Cell Cytokines as a Predictive Biomarker in Renal Transplantation

A. Cherukuri,¹ D. Chittka,¹ A. Sharma,¹ A. Salama,² C. Magee,² D. Rothstein.¹
Prospective Study of Switching from Tacrolimus to Low-Dose Cyclosporine A Preserving Allograft Function in BK Virus-Associated Nephropathy

G. Huang, X. Chen, S. Yang, C. Wang.
Prospective Trial Using Pulmonary Rehabilitation to Treat Frailty

C. Kennedy,¹ P. Novotny,² E. Stevens,¹ J. Kirsch,³ J. Garrett,¹ N. LeBrasseur,⁴ R. Benzo.¹
Prospective Validation of Prediction Models for Kidney Discard

S. Zhou, A. Massie, C. Holscher, M. Waldram, D. Segev.
Prospective, Double Blind, Randomized Trial Comparing the Use of Ketorolac and Lyrica versus SOC+placebo during Live Donor Nephrectomy for Transplant

J. Campsen,¹ T. Call,² A. Rosales,¹ C. Allen,³ A. Presson,³ R. Kim.¹
Prospective, Multi-Center Observational Study of Cell-Mediated Immunity for Cytomegalovirus Infection in Kidney Transplant Recipients

D. Kumar,¹ P. Chin-Hong,² L. Kayler,³ D. Wojciechowski,⁴ A. Limaye,⁵ O. Gaber,⁶ S. Ball,⁷ A. Mehta,⁸ T. Blanchard,⁹ C. Kotton.⁴
Prostate Cancer Characteristics in Men on Immunosuppressive Medications

M. Eltemamy, A. Elshafei, A. Salah, Y. Nyame, H. Arora, A. Wee, V. Krishnamurthi, S. Jones.
Protective Effect of Ceria-Nanoparticle on Renal Ischemia Reperfusion Injury in Rats

S-.I. Min,¹ S. Kim,² S. Kim,³ J. Ha.¹
Protein S Deficiency as an Independent Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients Awaiting Liver Transplantation

H-.C. Hung,¹ J-.C. Lee,¹ C-.H. Cheng,² Y-.C. Wang,² T-.H. Wu,² C-.F. Lee,² T-.J. Wu,² H. Chou,² K-.M. Chan,² W-.C. Lee.²
Proteinuria is Associated with Increased Risk for Cardiovascular Disease after Kidney Transplantation

R. Rahamimov,^1,2,3 M. Molcho,³ I. Vahav,³ A. Chagnac,^1,3 E. Mor,^2,3 B. Rozen-Zvi.^1,3
Protocol Biopsies after Paediatric Kidney Transplantation: A Single Centres' 17 Year Experience

T. Alsulaimi,¹ M. Aloufi,² S. Grisaru,¹ S. Samuel,¹ L. Hamiwka.¹
Protocolar Biopsies in Patients with Subclinical De Novo DSA in Kidney Transplantation

D. Bertrand,¹ M. Jaureguy,² C. Garrouste,³ J. Sayegh,⁴ N. Bouvier,⁵ S. Caillard,⁶ L. Lanfranco,⁷ A. Galinier,⁸ A. François,⁹ F. Hau,¹⁰ I. Etienne,¹ P. Gatault.¹¹
Proton Pump Inhibitor Use among Kidney Transplant Recipients

N. Wilson, S. Bala, B. Concepcion.
Proton-Pump Inhibitor Utilization is Associated with Higher Rates of Clostridium difficile Infection and Hypomagnesemia after Kidney Transplant

G. Kipp,² K. Dancsecs,¹ A. Lapping.¹
Providing Actual Echocardiographic Images to Centers Markedly Increases Transplantation of Deceased Donor Hearts

J. Trageser, C. Wainaia, L. Stocks, R. Steiner.
Providing Transplant Candidates with Guidance about Differences in Acceptance Criteria across Programs

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^4,7 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2
Providing Transplant Candidates with Patient-Specific Public Reports about Programs That Transplant Patients Like Them

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^7,4 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation

T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
Psychiatric Disorders and Disturbances in Transplant Listing Decisions

G. Lee, A. Wall, D. Magnus, J. Maldonado.
Psychosocial Assessment of Candidates for Transplantation (PACT) Identifies Non-Adherence in Pediatric Kidney Transplantation

K. Freischlag,¹ V. Chen,² S. Nagaraj,² A. Chua,² E. Chambers.²
Psychosocial Factors Affecting Recipients of Vascular Composite Allotransplantation

S. Rasmussen, M. Henderson, C. Cooney, J. Shores, W. Lee, D. Segev, G. Brandacher.
Psychotic Disorders and Outcomes after Kidney Transplantation

M. Molnar,^1,2 J. Eason,^1,2 A. Gaipov,³ M. Talwar,^1,2 P. Potukuchi,³ K. Kalantar-Zadeh,⁴ C. Kovesdy.^3,5
Pump Resistive Index Values and Not Preimplantation Kidney Biopsy Predict Kidney Allograft Survival

J. Liu,¹ A. Blumfield,¹ M. Trivedi,¹ N. Mishra,¹ O. Mohammed,^1,2 J. Lin,³ M. Ajaimy,^1,2 J. Graham,^1,2 J. Rocca,^1,2 E. Akalin,^1,2 S. Greenstein.^1,2
Pumping Donor Kidneys Reduces DGF and Improves Allograft Survival without Affecting Rejection Rates

M. Samoylova, A. Nash, T. Brennan.